MANISH MISHRA, Chief Executive Officer, Labaid Diagnostics As we stand on the cusp of a new era in healthcare, the future of diagnostics is taking shape with innovative technologies and novel approaches that promise to revolutionize medical testing. The convergence of various trends, such as artificial
clonoSEQ is the 1st U. S. Food and Drug Administration (FDA) cleared MRD test for Multiple Myeloma, Chronic Lymphoblastic Leukaemia (CLL), and B-Acute Lymphoblastic Leukaemia (B-ALL). clonoSEQ is a highly sensitive NGS based assay which is increasingly becoming the standard practices in patient management. MedGenome, South
The central theme of this prestigious forum is ‘Building Future-Ready Workforce’ India Skill Summit, jointly hosted by Pune based FUEL, FUEL Future Skills Institute and India CSR, will be held virtually on February 6, 2022. The day-long forum will witness visionary politicians, renowned corporate leaders and
1st December 2021: Dr. Harish Pillai has been appointed as the Chief Executive Officer of Metro Pacific Hospital Holdings Inc (MPHHI), which manages the largest private hospital network in the Philippines with 19 hospitals and 3750 beds, 2 allied healthcare colleges, a growing primary care
Pharma firm Cipla and Kemwell Biopharma on Wednesday announced the execution of a joint ventureagreement to develop, manufacture and commercialise biosimilars for global markets. For this purpose, a joint venture company shall be incorporated with an aim to enter the respiratory biosimilars space, Cipla said
Trivitron Mobile I-Lab rolled out for last mile COVID-19 testing access Trivitron Healthcare, a leading medical technology organization has announced the launch of Mobile Laboratory for Covid Testing to facilitate COVID-19 diagnostics in urban, rural areas and far-flung geographies to bring quality healthcare and diagnostic services near to
NANO H5 & NANO H110 to provide result within 130 seconds Trivitron Healthcare, a leading medical devices company has announced the launch of 2 new innovation driven products for HbA1c and Hb variant* detection. The new product includes NANO H5 & NANO H110 which are high performance
